Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026)

Astrazeneca (AZN) has reported FCF Payout Ratio for 17 consecutive years, with 6.01 the latest figure, recorded in Q1 2026.

• In Q1 2026, FCF Payout Ratio rose 22.98% year-over-year to 6.01; the TTM figure through Mar 2026 stood at 1.87 (up 17.19% YoY), while the FY2025 annual figure was 0.31, down 5.6% from the prior year.
• FCF Payout Ratio came in at 6.01 for Q1 2026 at Astrazeneca, down from 2.17 in the prior quarter.
• The five-year high for FCF Payout Ratio was 0.02 in Q2 2025, with the low at 13.57 in Q1 2022.
• Average FCF Payout Ratio over 5 years is 4.86, with a median of 3.36 recorded in 2024.
• Across the five-year window, FCF Payout Ratio declined 20.88% in 2022 and soared 65.9% in 2025, its largest moves.
• Year by year, FCF Payout Ratio stood at 13.57 in 2022, then surged by 99.4% to 0.08 in 2023, then tumbled by 3517.33% to 2.95 in 2024, then climbed by 26.44% to 2.17 in 2025, then slumped by 177.15% to 6.01 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 6.01, 2.17, and 2.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.